Stay updated on Semaglutide in Heart Failure & Obesity: Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Heart Failure & Obesity: Clinical Trial page.

Latest updates to the Semaglutide in Heart Failure & Obesity: Clinical Trial page
- Check4 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision number changes from v3.7.1 to v3.7.2.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page's revision history now shows a new revision v3.7.0 and removes the previous v3.6.6 entry, updating the version log.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing v3.6.5, indicating a minor site update. It does not reflect changes to the study record or primary content.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded revision v3.6.5 to the study history and removed v3.6.4, signaling a minor update to the page's release version. This reflects an update to the page's versioning in the history table rather than substantive changes to study data.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, signaling a small behind-the-scenes update to the page's build.SummaryDifference0.0%

Stay in the know with updates to Semaglutide in Heart Failure & Obesity: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure & Obesity: Clinical Trial page.